Minzhi Yu
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 8
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems 5
- Drug Solubulity and Delivery Systems 4
- Immunology top 10%
-
- RNA Interference and Gene Delivery 7
- Advanced biosensing and bioanalysis techniques 6
- Biomedical Engineering top 10%
-
- Cholesterol and Lipid Metabolism 6
- Lipoproteins and Cardiovascular Health 4
-
- Drug Transport and Resistance Mechanisms 4
- Co-authors
- Anna SchwendemanWenmin YuanJiancheng WangEmily E. MorinJames J. MoonSteven P. SchwendemanDan LiRui Kuai
- Partner nations
- United StatesChinaNorway
In The Last Decade
Minzhi Yu
34 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 104
- Biomaterials 398
- Pharmaceutical Science 128
- Immunology 248
- Molecular Biology 632
- Biomedical Engineering 325
Countries citing papers authored by Minzhi Yu
This map shows the geographic impact of Minzhi Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minzhi Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minzhi Yu more than expected).
Fields of papers citing papers by Minzhi Yu
This network shows the impact of papers produced by Minzhi Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minzhi Yu. The network helps show where Minzhi Yu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Minzhi Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 6 | |
| 6 | 2023 | 18 | |
| 7 | 2023 | 21 | |
| 8 | 2022 | 15 | |
| 9 | 2022 | 10 | |
| 10 | 2022 | 6 | |
| 11 | 2021 | 21 | |
| 12 | 2020 | 29 | |
| 13 | 2020 | 11 | |
| 14 | 2020 | 33 | |
| 15 | 2019 | 10 | |
| 16 | 2019 | 145 | |
| 17 | 2018 | 110 | |
| 18 | 2018 | 116 | |
| 19 | 2016 | 112 | |
| 20 | 2016 | 33 |
About Minzhi Yu
Minzhi Yu is a scholar working on Pharmaceutical Science, Structural Biology and Biomaterials, having authored 38 papers that have together received 1.3k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (8 papers), RNA Interference and Gene Delivery (7 papers), Cholesterol and Lipid Metabolism (6 papers), Advanced biosensing and bioanalysis techniques (6 papers), Advanced Drug Delivery Systems (5 papers), Drug Solubulity and Delivery Systems (4 papers), Lipoproteins and Cardiovascular Health (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). The work is most often cited by research in Biomaterials (398 citations), Pharmaceutical Science (128 citations) and Immunology (248 citations). Minzhi Yu has collaborated with scholars based in United States, China and Norway. Frequent co-authors include Anna Schwendeman, Wenmin Yuan, Jiancheng Wang, Emily E. Morin, James J. Moon, Steven P. Schwendeman, Dan Li, Rui Kuai, Qiang Zhang and Chong Qiu. Their work appears in journals such as Journal of Biological Chemistry, ACS Nano and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.